148 results
Page 4 of 8
CORRESP
141v j819dtb
2 Mar 21
Correspondence with SEC
12:00am
D
hb02h4gvona66eorb2sl
1 Feb 21
$10M in equity / options / securities to be acquired, sold $10M, 10 investors
4:18pm
8-K
EX-99.1
bxtp 51o6v7jfno
21 Jan 21
NeuroBo Pharmaceuticals Announces $10.0 Million Private Placement
5:03pm
8-K
EX-10.2
lbutwhs 319ogtrzzxqs
21 Jan 21
NeuroBo Pharmaceuticals Announces $10.0 Million Private Placement
5:03pm
8-K
EX-10.1
tupidzl3
21 Jan 21
NeuroBo Pharmaceuticals Announces $10.0 Million Private Placement
5:03pm
8-K
EX-99.2
xeh iw8jsm2
21 Jan 21
NeuroBo Pharmaceuticals Announces $10.0 Million Private Placement
5:03pm
D
onh5 cu26w
12 Jan 21
$17.03M in equity, sold $17.03M, 34 investors
2:22pm
8-K
EX-2.1
zcpwutna1j cmk
6 Jan 21
NeuroBo Pharmaceuticals Acquires ANA Therapeutics for Late-Stage Oral Antiviral Development Program
4:05pm
8-K
EX-10.1
4ydbr6eg6xhyvcw
6 Jan 21
NeuroBo Pharmaceuticals Acquires ANA Therapeutics for Late-Stage Oral Antiviral Development Program
4:05pm
8-K
EX-99.1
gncx0lac0ih 7tbi6fdi
26 May 20
NeuroBo Pharmaceuticals Announces Continuation of Partial
8:39am
424B5
ivgftio7
15 Apr 20
Prospectus supplement for primary offering
5:19pm
8-K
EX-10.1
vfo2 xfvg
15 Apr 20
NeuroBo Pharmaceuticals Announces $7.5 Million Registered Direct Offering
5:13pm
8-K
EX-99.1
xwg 52r7xfzx2
15 Apr 20
NeuroBo Pharmaceuticals Announces $7.5 Million Registered Direct Offering
5:13pm
8-K
EX-99.1
scj8daqkghufxgm9ke
30 Mar 20
NeuroBo Pharmaceuticals Reports Year End 2019 Financial Results and Provides Corporate Strategic Update
5:23pm